Topics
Trends and Innovations in Retina
Business Matters: Branding Your Practice
Editorially Independent Content Supported with Advertising by Genentech and Regeneron
View Supplement
How to Combat Challenges Faced in Obtaining Access to Approved Anti-VEGF Medications
This CME activity is supported through an educational grant from Regeneron Pharmaceuticals, Inc.
Identifying the Optimal Patient Type for RETISERT Treatment
Sponsored by Bausch + Lomb
Retinal Imaging
Novel Treatment Strategies for Macular Edema Associated With Noninfectious Uveitis
This CME activity is supported through an educational grant from Clearside Biomedical, Inc.
Diabetic Retinopathy: Changing Treatment Paradigms
Editorially Independent Content, Supported With Advertising From Genentech and Carl Zeiss Meditec
View Interactive Supplement
Rare and Inherited Retinal Diseases
Clarifying the Clinical Applications of Photodynamic Therapy: Current Concepts and Use in 2018
This CME activity is supported by an educational grant from Bausch + Lomb.
SubLiminal Laser Therapy for Central Serous Chorioretinopathy
Sponsored by Quantel Medical
View Insert
Business Matters: Protect Your Assets
Clinical Case Compendium
Editorially Independent Content, Supported With Advertising From Alcon and Topcon
Level Up
Perspectives on Treatment With OZURDEX (dexamethasone intravitreal implant) 0.7 mg
Sponsored by Allergan
Treating Retinal Disorders: Updates for the Newer Retina Specialist
This CME activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.
Digital 3D Retina Surgery: Are We at the Precipice of a New Standard of Care?
Sponsored by Alcon
Swept Source OCT & OCT Angiography
Sponsored by Topcon
AMD
Business Matters: A New Direction for Maintenance of Certification
Editorially independent content supported with advertising by Genentech and Regeneron
Articulation and Illumination Are the Crucial Features of the VEKTOR Laser Probe
Intelligence Amplification: How EMR Systems Might Actually Help Improve Health Care Delivery
Sponsored by Modernizing Medicine
Identifying and Addressing Market Access Challenges With Anti-VEGF Therapies for Patients With Retinal Disease
On The Case
The XX Factor
Business Matters: Is Private Equity Right for Your Practice?
Multi-Modality Imaging: Latest Evolutions in OCTA and UWF
Sponsored by ZEISS
Surgical Efficiency With Smaller-Gauge Instruments
Year in Review 2017: Present and Future Retina Therapies
This continuing medical education activity is supported through an educational grant from Regeneron Pharmaceuticals, Inc.
Technique Meets Technology
A Clinical Trial of YAG Vitreolysis by Retinal Specialists
Sponsored by Ellex
From Trials to Treatment: Real-World Applications in Medical and Surgical Retina (Part 3 of 3)
This continuing medical education activity is supported through an unrestricted grant from Regeneron Pharmaceuticals, Inc.
The Multicenter Uveitis Steroid Treatment (MUST) Trial: A Closer Look at the 7-Year Findings
Free Print Subscription
Email Newsletter
Conference Calendar
April 17, 2026
Phase 1 Data for Vamikibart Published in JAMA Ophthalmology
MeiraGTx Announces the Acquisition of XLRP Therapy From J&J
April 16, 2026
Experimental Light-Activated Therapy Shows Early Promise for Retinitis Pigmentosa
April 15, 2026
Curative Biotechnology Engages Sterling Pharmaceutical Services to Manufacture Clinical Supply for Ophthalmic Program
